NCT04009265View on ClinicalTrials.gov

Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

819

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2027

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
COMBINATION_PRODUCT

adjuvant treatment

adjuvant treatments include chemotherapy or chemoradiotherapy

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER